Robert Lugliani
Pulmonary Disease · Long Beach, CANPI 1699712943
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 147 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 23.8% — the pattern of someone who eats at a lot of different presentations.
Across 147 payments — averaging $19.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$693
- GSK$676
- Mylan Specialty L.p.$407
- Pfizer$288
- Regeneron Healthcare Solutions, Inc.$209
- Vanda Pharmaceuticals Inc.$140
- plus $497 from 16 others
What the payments were for
- Food & beverage$2,908100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 37 | $693 |
| GSK | 36 | $676 |
| Mylan Specialty L.p. | 22 | $407 |
| Pfizer | 13 | $288 |
| Regeneron Healthcare Solutions, Inc. | 6 | $209 |
| Vanda Pharmaceuticals Inc. | 5 | $140 |
| Sunovion Pharmaceuticals Inc. | 8 | $96 |
| Eisai Inc. | 3 | $60 |
| AbbVie | 2 | $46 |
| Gilead | 2 | $40 |
| Philips North America LLC | 2 | $39 |
| Electromed, Inc. | 1 | $33 |
| Baxter Healthcare | 1 | $30 |
| Nabriva Therapeutics, PLC | 1 | $24 |
| Paratek Pharmaceuticals, Inc. | 1 | $22 |
| Almatica Pharma LLC | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
| Boehringer Ingelheim | 1 | $17 |
| Merck | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| Inogen, Inc. | 1 | $13 |
| Johnson & Johnson | 1 | $13 |
How this compares
$2,908 in reported general payments places this provider in the 60th percentile of 1,261 pulmonary disease providers in California.
Other pulmonary disease in Long Beach
- Samuel LouieSacramento$2.8M
- Shyamsunder SubramanianTracy$1.5M
- Toby MaherLos Angeles$1.3M
- Rajkumar DasguptaPasadena$930K
- Hoang leFountain Valley$814K
- Kevin FussellEncinitas$788K
- Revati ShreeniwasStanford$726K
- David PhamWestminster$571K
- Vijay BalasubramanianFresno$529K
- Victor TapsonLos Angeles$514K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.